Tricor 145 kahi mea mālama waha hypolipidemic e hoʻohana i ka hana lapaʻau e hoʻohaʻahaʻa i nā kolamu kiʻekiʻe a me nā triglycerides. Pono ke kāpae ʻia o ka hypercholesterolemia e hōʻemi i ka hopena o ka hoʻomohala ʻana i ka atherosclerosis a i ka nānā ʻana i ka hoʻokumu ʻana o nā palaka atherosclerotic ma nā paia o ka moku. ʻO ka lāʻau lapaʻau e hōʻemi i ka hopena o nā clots koko ma muli o ke kaohiʻana o ka hoʻohui o nā platelets koko.
Inoa Kūʻai ʻole honua
Fenofibrate.
Hoʻohana ʻia ʻo Tricor 145 e hoʻohaʻahaʻa i ka cholesterol kiʻekiʻe a me nā triglycerides.
ATX
C10AB05.
E hoʻokuʻu i nā palapala a me ka ʻano
Loaʻa ka lāʻau lapaʻau i nā papa keʻokeʻo no ka hoʻoponopono o waha. Aia i kēlā me kēia papa o ka lāʻau lapaʻau ka 145 mg o ka mea ikaika - fenofibrate nanoparticles. Hoʻohana ʻia kēia mau mea e hoʻonui i ka wikiwiki a me ka hoʻopiha piha ʻana i ka hoʻohuihui ʻana me ka mea ikaika.
- crospovidone;
- huki;
- mikulamulamina selulose;
- sodium lauryl sulfate a hoʻāʻālua;
- waiū waiʻa, sucrose;
- colloidal dehydrated silicon dioxide;
- paʻahau magnesium.
Loaʻa ka Tricor 145 i loko o nā papa keʻokeʻo no ka hoʻokūkū waha a loaʻa iā 145 mg o ka hoʻohui kaha - fenofibrate nanoparticles.
Ua uhi ʻia nā papa ma kahi membrane kiʻi ma luna, kahi e hoʻokahe ma lalo o ka hana o nā esterases ʻōpū. ʻO ka kiʻiʻoniʻoni ka mea o ka alkohol polyvinyl, titanium dioxide, talc, soya lecithin, xanthan gum.
ʻAʻole ʻano ʻano:
- gulu;
- injections in ampoules.
Ka hana lāʻau lapaʻau
ʻO ka lāʻau hypoglycemic pā ma ka hui o fibrates. Kuhi ʻia ka hana o ka hana o ka mea hoʻomehana i ka hoʻopili ʻia ʻana o nā mea ʻohi alpha. Ma muli o ka hoʻonui nui ʻana o kā lākou hana, hoʻonui ʻia ka lipolysis a me ka hoʻopuka o nā lipoproteins me kahi kiʻekiʻe o ka triglycerides.
Kūkulu ʻia ka Fenofibrate mai ka fibric acid, i hiki iā ia ke hoʻopilikia i ka pae o lipids i ke kino kanaka ma muli o ka hoʻihoʻi ʻana o nā ʻāpana alpha. Ma muli o ka loaʻa ʻana o ka hopena therapeutic, ua hoʻemi ʻia ka piʻiʻana o ka lipoproteins low density (LDL) a laila i hoʻonui ʻia ke kiʻekiʻe o ka haʻahaʻa kiʻekiʻe (HDL). Ua hōʻike ka mua o nā hoʻokolohua preclinical i ka hōʻemi o ka nui o ka cholesterol ma 25%, triglycerides e 45-55% a me ka hoʻonui ʻana o ka pae HDL i ka 10-30%.
I ka wā o ka mālama conservative therapy, hoʻemi ʻia ka hopena o ka hoʻomohala ʻana i ka loli atherosclerotic i ka endothelium vascular a ua hōʻemi ʻia ka hopena o ka hoʻokumu ʻana o nā palakiko koleka ma nā paia o ke kahe koko. Me ka hoʻohana mau ʻana o ka lāʻau lapaʻau, emi ka helu o nā hōʻailona o ka ʻaihue. Ma ka heleʻana o ka hyperuricemia, loaʻa i nā mea maʻi ka hoʻomaʻamaʻa hou aʻe ma ke ʻano o ka emi ʻana o 25% ma ka pae waikawa uric.
Tricor 145 - kahi lāʻau lapaʻau hypoglycemic pili i ka hui o fibrates.
Lapaʻau lāʻau
Ke komo nei lākou i nā ʻāpana, hoʻohālikelike ʻia nā papa e nā esterases e hana ai i ka acidofofroic acid. Hoʻopili ke lāʻau lāʻau i ke kahe o ke koko, kahi e loaʻa ai nā waiwai nui loa i loko o nā hola 2-4. Hoʻonui ʻia ka huahana metabola o ka pā i loko o ka pā i loko o ke ʻano o ka nanoparticles, no laila ʻo ka hoʻohana ʻana i ka ʻai i ka ʻai ʻaʻole i pili i ka helu o ka komo ʻana a me ka piha piha o ka bioavailability. I loko o nā kīʻaha koko, 99% o ka waikawa fenofibroic ikaika e hana i kahi paʻakikī me ka albumin plasma.
ʻAʻole pono ka lāʻau lapaʻau i ka loli i loko o nā puʻuwai o ke ake. ʻO ka hapalua ola o ka metabolite mau manawa he 20 mau hola. Ke waiho nei ka lāʻau i ke kino me ka urine i loko o hoʻokahi pule.
Nā hōʻailona no ka hoʻohana ʻana
Hoʻohana ʻia ka lāʻau lapaʻau no ka kiʻekiʻe o ka cholesterol a me ka triglycerides a i ʻole me ka dyslipidemia i hoʻohui ʻia me ka haʻahaʻa haʻahaʻa o ka lāʻau meaʻai, i hoʻoikaika ʻia ke kino kino a me nā ʻano lāʻau ʻē aʻe i ka hakakā me ka ʻoi ʻana. Ma mua o ka heleʻana o ka hypertension arterial a me nā hana ʻino.
Ma ka hana lapaʻau, hiki i kahi lāʻau lapaʻau ke hoʻopau i ka maʻi metabolic a me ka hyperlipoproteinemia kūmole inā wale nō ka hoʻonui ʻana o ka pae lipoproteins inā he maikaʻi ʻole ka mālama ʻana i ke kaʻina hana nui.
Hoʻohana ʻia ʻo Tricor 145 no ka kiʻekiʻe o ka kolamu a me ka triglycerides a i ʻole a me ka dyslipidemia i hui ʻia me ka lāʻau hoʻomōʻai kino maikaʻi.
Nā Hoʻohui
Hoʻopau maikaʻi ʻia ka lāʻau i kēia mau hihia:
- me ka galactosemia koʻikoʻi, lactase a me ka nele o ka fractose, ka maʻi galactose-glucose, sucrose-isomaltase malabsorption;
- ka heleʻana o ka hoʻoulu ʻana i ka mālamalama i ka mālamalama, i nā māhele hana Tricorra;
- akeʻa a me nā hemahema;
- phototoxicity i ka wā hana me Ketoprofen, hoʻonuiʻia;
- ʻōnaehana helehelena ma ka pīpī;
- kahi anaphylactic ʻano hopena i nā pīkī, soy a me ka pīni iʻa.
Me ka mālama pono
Pono e nānā pono i ke kūlana o ka mea maʻi i ka wā i koho ʻia e kū'ē i kahi kūlana o kēia mau maʻi.
- mālie i ka lewa māmā a me ka maʻi hepatic;
- lāleʻa hemahema;
- ʻoi aku ke kiʻekiʻe;
- he ʻano hoʻoilina he nui o ka maʻi ʻāla;
- parallel therapy me indirectagulants kūlike a me HMG-CoA reductase blockers.
Pono e nānā pono i ke kūlana o ka mea maʻi i ka wā i hoʻākāka ʻia ai i kahi kū mua o ka waiʻona maʻi.
Pehea e lawe ai iā Tricor 145 mg
Pono e lawe ʻia nā papa ʻōlelo ʻole me ka ʻaika ʻole. Hiki ke hōʻeha i ka membrane kiʻi ʻoniʻoni ke alakaʻi i ka hōʻemi o ka hoʻololi o ka fenofibrate i ka acid fenofibric ikaika. Hiki ke kiʻi ʻia ka lāʻau i ke ao holoʻokoʻa, me ka manaʻo o ka meaʻai. Pono ka poʻe maʻi maʻi inu i ka papa ʻaina 1 145 mg i kēlā me kēia lā.
Maikaʻi ka hopena lipid-hoʻohaʻahaʻa i ka wā e hoʻomau ai ka papa ʻaina a i nā kūlana o ka hoʻonui kino kino. ʻAʻole nā mea maʻi i mālama ʻia me ka 160 mg o ka lāʻau lapaʻau, ʻaʻole pono e hōʻemi iki i ka dosis ma ka 145 mg.
Lawe i ka lāʻau lapaʻau no ka maʻi maʻi maʻi
ʻAʻole pili ka lāʻau lapaʻau i ka pae o ka glucose i ke koko a me ka hana o nā cell beta pancreatic. No laila, ʻaʻole nā mea maʻi me ka diabetes mellitus e pono ai i ka hoʻoponopono ʻana o ka maʻi o nā lā a me ka lāʻau hypoglycemic dosage.
Nā hopena hopena
Hōʻike nā hopena maikaʻi o ke kino ma muli o kahi inapo i koho ʻia ʻo ka fenofibrate.
ʻŌpala Gastrointestinal
Hōʻike ʻia nā maʻi ʻōnaehana digestive e like me ka ʻeha ma ka epigastrium, luaʻi, hoʻomohala ʻana a me ka maʻi ʻōpū. Hiki paha ke pancreatitis.
ʻO nā mea maʻi me ka maʻi mellitus maʻi ʻole e koi aku i ka hoʻoponopono ʻana o ka dosage i nā lā a me nā lāʻau lapaʻau hypoglycemic.
Hematopoietic mau hui
I nā hihia lohi, me ka hoʻoneʻe ʻana o ke kaila a me nā pūnaehana lymphatic, pio ka leukocyte a hoʻonui i ka hemoglobin e hoʻonui.
Pūnaehana pīhoihoi waena
Hōʻikeia kekahi ʻōlaʻi o ka pilikia me ka maikaʻi o ka erectile dysfunction, ʻeha.
Mai ka ʻōnaehana musculoskeletal a me nā ʻaoʻao pili
I nā hihia ʻokoʻa a keu ʻole, hiki i ka hoʻomohala ʻana o ka myalgia diffuse, nā mākīkī o nā māla a me nā mānoanoa, nāwaliwali, myositis, ka nehu o ka ʻoiwi o nā mākala o ka ʻāwīwī o nā ʻīwī.
Mai ka papa huhū
Aia ka liʻiliʻi liʻiliʻi e hoʻomohala ana i ka maʻi pneumopathy interstitial.
Ma ka ʻāpana o ka ʻili a me nā momona subcutaneous
ʻO ka hōʻeha ʻana o nā maʻi kūlohelohe maʻi maʻi, ka hiʻohiʻona e ka hiʻohiʻona o ke ʻano nui, urticaria, ʻeha nui. I kekahi mau hiʻohiʻona, hoʻonui ka naʻau i ka mālamalama i ka ʻili, hoʻomaka ke kanaka e nalowale i ka lauoho. Hiki pū ʻia nā Photosensitivity e erythema, ka hopena o nā palia.
Mai ka pūnaehana genitourinary
Hiki ke hoʻonui iki i ka likum serum a me ka pae o ka uric acid i ke kūmole o ka noho ʻana o ka urinary.
Mai ka pūnaehana cardiovascular
Hōʻike ka maʻi vascular e ka thromboembolism venous, ʻo ia hoʻi me ka embolism pulmonary a me ka thrombosis venous ma nā ʻaoʻao o lalo.
ʻŌnaehana Endocrine
Hoʻohui nui paha.
Ma ka ʻāpana o ka ate a me ka pāpaʻi biliary
I ka nui o nā hihia, hoʻonui ʻia ka hana a me ka loaʻa ʻana o nā aminotransferases hepatic i loko o ka serum koko. I kekahi mau hihia, ulu ka cholelithiasis, hiki i ka manawa maʻamau ka wā o ka ate. Inā loaʻa nā hōʻailona o ka hepatitis i ke ʻano o ka jaundice a me ka haki, ua manaʻo ʻia e hoʻomō i nā hoʻokolohua hoʻopaʻa ʻana e hōʻoia i ka maʻi maʻi. I ka loaʻa ʻana o nā hopena kūpono, hoʻopau ʻia ka hoʻohana ʻana o ka fenofibrates.
Nā ʻōlelo kikoʻī
Ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau, pono e hoʻopau i nā kumu etiological o ka hypercholesterolemia lua, hiki iā ia ke kū i ke kūpaʻa o ke ʻano o ke ʻano maʻi diabetes mellitus, ʻokoholā. Hoʻomaopopo ʻia ka hopena o ka mālama ʻia e nā ʻōkuhi o ka lāʻau ʻomū i nā pae momona o ka serum. I ka hana ʻole ʻana o nā hana lipid-kaomi i loko o 3 mau mahina, pono ke kūkā me kāu kauka e pili ana i ka loaʻa o ka lāʻau lapaʻau.
I kekahi mau hihia, e kū'ē ana i ke kua o ke ʻano o ka lāʻau lapaʻau, hiki i ka hoʻomohala ʻana o ka hana o ka maʻi i ka pancreas.
I kekahi mau hihia, e kū'ē ana i ke kua o ke ʻano o ka lāʻau lapaʻau, hiki i ka hoʻomohala ʻana o ka hana o ka maʻi i ka pancreas. ʻO nā kumu o ka pancreatitis hiki i nā pōhaku a me ke kūpeʻe pila ma ka ʻili o ka puʻuwai, ʻaʻole lawa o ka hopena therapeutic e pili ana i ke kua o ka hypertriglyceridemia koʻikoʻi.
Hoʻopilikia i ka hiki ke mālama i nā mīkini
ʻAʻole kope ka lāʻau a me ka psychotropic, ʻaʻole i hoʻopilikia i ka hana o ke ʻano hanana o ke kikowaena a me nā peripheral. No laila, i ka wā o ka mālama ʻana me Triicore, e ʻae ʻia e kaohi i nā ʻenekini a me kahi kaʻa, ʻo ia ka mea e koi ai ka piʻi ʻana a me ka wikiwiki.
Hoʻohana i ka wā hāpai a me ka lactation
Kuhi ʻia ka wai lipid-hoʻēmi ʻia i ka wā hāpai. Ke koho ʻana i nā lāʻau lapaʻau i ka wā o ka hōʻuluʻulu ʻana, pono ia e hoʻoneʻe i ke keiki i ka meaʻai me nā pēpē pēpē a kāpae i ka lactation.
Kahi ʻana i ka TRICOR 145 mg i nā keiki
Lā ʻia ka maʻi hypolipidemic oral e piʻi i ka 18 mau makahiki ma muli o ka hemahema o ka ʻike i ka hopena o ka waila fenofibroic e hoʻomohala ana i ke kino o ke kanaka ma ke kula a me nā wā ʻōpio.
Hoʻohana i ka wā kahiko
ʻO nā kānaka i ʻoi aku ma mua o 70 mau makahiki e pono e kiaʻi pono i ko lākou kūlana i ka wā e mālama ai me ka fenofibrate.
Ke noi no ka hana renal haukapole
Hoʻokomo ʻia ka lāʻau lapaʻau i loko o ka hana ʻoi kino.
Hoʻohana no ka hana lawelawe lēwa
Lā ʻia ka lāʻau lapaʻau no ka hoʻohana ʻana e nā poʻe me ka maʻi ʻeha koʻikoʻi.
Ke keu
ʻAʻole i kūkulu ʻia kahi mea kikowaena kūlike kūpono ʻole. ʻO kēia ma muli o ka loaʻa ʻole o nā hihia overdose. Me ka hoʻohana pā hoʻokahi o nā papa kiʻekiʻe o nā papa, e hypothetically e hoʻonui i nā hopena ʻaoʻao a hoʻonui i ko lākou ʻike. Inā kānalua ʻoe i ka hōʻailona o ka overdose, pono ʻoe e ʻimi i ke kōkua olakino. ʻAʻole hōʻino ʻia ka lāʻau lapaʻau e nā hemodialysis.
ʻAʻole pāpā loa ia e inu i ka waiʻona i ka wā o ka maʻi Tricor.
Hoʻopili pū me nā lāʻau ʻē aʻe
ʻO Fenofibrate a me kāna huahana metabolic ʻaʻole i pale i nā isoforms cytochrome P450.
Hoʻolaha ka waipuna
ʻAʻole pāpā loa ia e inu i ka waiʻona i ka wā o ka maʻi Tricor. Hiki i ka Ethyl alkohol ke hoʻonāwaliwali i ka hopena lipid-hoʻemi i lalo, no ka pale ʻana i ka hepatobiliary a me ka ʻōnaehana saraf.
Hoʻohui hui like ʻole
Hoʻonui ka acid Fenofibroic i ka hopena therapeutic o ka anticoagulants no ka hoʻohana waha. Ma muli o kēia hui pū ʻana, hiki paha i ke kaʻe koko kūloko. ʻO ka hopena hopena ma muli o ka hoʻokuʻu mai o kahi anticoagulant mai ka pākeke pili protein protein.
I ka hoʻomaka ʻana o nā lāʻau lapaʻau me ka fenofibrate, ke kuhi ʻia e nīnau aku i kekahi kauka e pili ana i ka pono e hoʻemi i ka papaʻi o kēlā me kēia lā o nā anticoagulants e ⅓ Hoʻopili ʻia ke koho ʻana ma muli o ke ʻano o nā moʻo o INR.
Me ka hoʻohana pā hoʻokahi o nā papa kiʻekiʻe o nā papa, e hypothetically e hoʻonui i nā hopena ʻaoʻao a hoʻonui i ko lākou ʻike.
ʻAʻole i hāʻawi ʻia
Ma muli o ka hiki nui o ka hopena o ka hopena o ka hopena i ka ʻeha, ʻaʻole i ʻōlelo ʻia ʻia nā blockers reductase a me ka HMG-CoA.
ʻO nā hui e koi ana i ka mālama
Manaʻo ʻia e kiaʻi i ka hana maʻamau o nā keiki i ka wā e koho ʻia ai ʻo Tricor me Cyclosporine a i ʻole antibiotics. Ke hui pū ʻia, loaʻa kahi pilikia o ka hāʻule ʻole o ka pūpū. Me nā loli ikaika i ka ʻōnaehana kāpili, pono ʻoe e ʻae i ka lawe ʻana iā Tricor.
Nā kuʻina
Hiki ke hoʻololi ʻia ka lāʻau lapaʻau me kekahi o nā mea i aneʻa aʻe:
- Lipantyl;
- Canon Fenofibrate;
- Gofibrat;
- Lofant
ʻO nā kūlana hoʻomaha o Treicor 145 mg mai nā lāʻau lapaʻau
Loaʻa wale nā peni i nā ʻōlelo lapaʻau pololei.
Hiki iaʻu ke kūʻai me ke kī ʻole
ʻAʻole kūʻai ʻia ka lāʻau lapaʻau me ka loaʻa ʻole o ka kauka kauka ma muli o ka nui o ka hopena o nā hopena ʻaoʻao inā hoʻohana ʻole ʻia.
Kūʻai
ʻO ka kumukūʻai kumukūʻai o nā papa he 931 mau rubles.
Ke waiho nei i nā kūlana no ka lāʻau lapaʻau
Pono e hoʻokomo i ka lāʻau lapaʻau ma ka hoʻohaʻahaʻa haʻahaʻa ʻoi loa mai nā hihi ultraviolet i nā mahana a hiki i + 25 ° C.
ʻO ka lā kau
3 mau makahiki
Tricor 145 mg
Reciphon Fontaine, Farani.
Hiki ke hoʻololi ʻia ka lāʻau lapaʻau me ka Canon Fenofibrat Canon.
Hōʻikeʻike e pili ana iā Tricor 145 mg
Ma nā kūkākūkā pūnaewele, waiho nā kauka a me nā mea maʻi i nā ʻōlelo maikaʻi. Ke kū nei nā loiloi maikaʻi ma muli o ke ʻano o nā hopena ʻaoʻao.
Kauka
Romanov Denis, endocrinologist, St. Petersburg
He lāʻau palama lipid-hoʻēmi kēia, akā Tricor e hōʻemi i ka triglycerides koko i kahi nui. Hoʻomaopopo wau i ka hoʻohana ʻana iā ia no ka dyslipidemia o nā ʻano IIa, IIb, III a me IV. Hoʻokomo ʻia nā maʻi a me ka lōʻihi o ka mālama ʻana i kēlā me kēia kanaka. ʻAʻohe hopena maikaʻi loa i nānā ʻia i nā mea maʻi. Ke hoʻomaopopo aku nei au iā ʻoe i ka hoʻomaʻamaʻa, he haʻahaʻa loa ka lāʻau i ka hoʻohaʻahaʻa ʻana i ka cholesterol. Hoʻopili ʻia nā pākaukau no nā poʻe me ka hana naʻau maʻamau.
ʻO nā maʻi maʻi
Gennady Likhachev, 38 makahiki, Yekaterinburg
Ke waiho nei au i kahi loiloi maikaʻi ʻole e pili ana iā Tricor. Ua kuhikuhi aku ke kauka i ka lāʻau lapaʻau ma kahi o ka pono o Torvacard, no ka mea, aia kahi haʻahaʻa o HDL. Ma hope o 4-5 mahina o ka hoʻokomo ʻana, ʻike wau i ke ʻano o nā wā maʻamau o ka pua o ka pua, ka pupu a i ka luaʻi. I nā 8-9 mahina o ka mālama ʻana i ka maʻi conservative, ua hoʻolālā ʻia kahi hana hoʻolālā e pili ana me ka maʻi puhipuhi a me ka like o ka colic i ka gallbladder. ʻO ka wehe ʻana o ka gallbladder i hōʻike ai i ka bile viscous a me nā pōhaku he nui. Ma hope o ka hana, ua pau nā mea kaua.
Roma Sorokin, 53 makahiki, Stavropol
Loaʻa au i ka retinopathy maʻi maʻi, e pili ana i kaʻu hana ʻana i ka laser a me nā hana ʻoi loa ma luna o koʻu mau maka ma mua o ka hoʻokahi. I mea e wikiwiki ai ka hoʻihoʻi, ke ʻae aku nei au iā Tricor, ka mea kūpono me ka hana. I kēia hihia, hōʻemi ka lāʻau kolohe i ka nui o ke kolamu ma ke koko i nā pae maʻamau. Inu wau i ka lāʻau lapaʻau ma ka papa maʻamau no 10 mau mahina, ukali ma kahi hoʻomaha o 2 mau mahina. ʻAʻole wau i ʻike i nā hopena a me nā hopena kūlohelohe i ka wā o ka intake holoʻokoʻa.
